My bookmarksSign up free
Source

Commission Implementing Decision (EU) 2021/1105 of 5 July 2021 on the recognition of the legal, supervisory and enforcement arrangements of Singapore for derivatives transactions supervised by the Monetary Authority of Singapore as equivalent to certain requirements of Article 11 of Regulation (EU) No 648/2012 of the European Parliament and Council on OTC derivatives, central counterparties and trade repositories (Text with EEA relevance)

Commission Implementing Decision (EU) 2021/1105 of 5 July 2021 on the recognition of the legal, supervisory and enforcement arrangements of Singapore for derivatives transactions supervised by the Monetary Authority of Singapore as equivalent to certain requirements of Article 11 of Regulation (EU) No 648/2012 of the European Parliament and Council on OTC derivatives, central counterparties and trade repositories (Text with EEA relevance)

Implementing Decision (EU) 2021/1105 · Decision · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

For the purposes of Article 13(3) of Regulation (EU) No 648/2012, the legal, supervisory and enforcement arrangements of Singapore for trade confirmation, portfolio compression and reconciliation, valuation and dispute resolution that are applied to transactions regulated as OTC derivatives by the Monetary Authority of Singapore (‘MAS’) and that are not cleared by a CCP shall be considered as equivalent to the corresponding requirements set out in paragraphs 1 and 2 of Article 11 of Regulation (EU) No 648/2012, where at least one of the counterparties to those transactions is established in Singapore and is a ‘MAS Covered Entity’ as defined under the Guidelines on margin requirements for non-centrally cleared OTC derivative contracts.

Article 2

Open ↗

For the purposes of Article 13(3) of Regulation (EU) No 648/2012, the legal, supervisory and enforcement arrangements of Singapore for the exchange of collateral that are applied to transactions regulated as OTC derivatives by the MAS and that are not cleared by a CCP, with the exception of physically-settled commodity derivatives for commercial purposes, shall be considered as equivalent to the requirements of paragraph 3 of Article 11 of Regulation (EU) No 648/2012, where the following conditions are satisfied: (a) at least one of the counterparties to those transactions is established in Singapore and is a MAS Covered Entity as defined under the Guidelines on margin requirements for non-centrally cleared OTC derivative contracts of Singapore; (b) where variation margin is required to be provided under Regulation (EU) No 648/2012, variation margin is exchanged on the same day in which it is calculated. By way of derogation from point (b), where it is established between the counterparties that variation margin cannot consistently be provided on the same day in which it is calculated, the legal, supervisory and enforcement arrangements of Singapore shall also be considered as equivalent to the requirements of Art. 11(3) of Regulation (EU) No 648/2012 where variation margin is exchanged within two business days of its calculation and the margin period of risk used to calculate initial margin is adjusted accordingly.

Article 3

Open ↗

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Other acts of the same type
Decision (EU) 2021/2255 of the European Central Bank of 7 December 2021 on the approval of the volume of coin issuance in 2022 (ECB/2021/54)Commission Decision (EU) 2021/2312 of 7 December 2021 on the long-term national aid scheme for agriculture in the northern regions of Finland (notified under document C(2021) 8773) (Only the Finnish and Swedish texts are authentic)Council Decision (CFSP) 2021/2160 of 6 December 2021 amending Decision (CFSP) 2020/1999 concerning restrictive measures against serious human rights violations and abusesCouncil Decision (CFSP) 2021/2161 of 6 December 2021 amending Decision (CFSP) 2018/1788 in support of the South-Eastern and Eastern Europe Clearinghouse for the Control of Small Arms and Light Weapons (SEESAC) for the implementation of the Regional Roadmap on combating illicit arms trafficking in the Western BalkansCommission Implementing Decision (EU) 2021/2184 of 6 December 2021 concerning the extension of the actions taken by the Health and Safety Executive of the United Kingdom permitting the making available on the market and use of five biocidal products for hand disinfection in accordance with Article 55(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2021) 8729) (Only the English text is authentic)Commission Implementing Decision (EU) 2021/2185 of 6 December 2021 concerning the extension of the action taken by the Health and Safety Executive of the United Kingdom permitting the making available on the market and use of the biocidal product Micronclean Hand Sanitiser in accordance with Article 55(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2021) 8736) (Only the English text is authentic)Commission Implementing Decision (EU) 2021/2145 of 3 December 2021 not to suspend the definitive anti-dumping duties on imports of birch plywood originating in Russia imposed by Implementing Regulation (EU) 2021/1930Commission Implementing Decision (EU) 2021/2146 of 3 December 2021 postponing the expiry date of approval of N,N-diethyl-meta-toluamide for use in biocidal products of product-type 19 (Text with EEA relevance)Commission Decision (EU) 2021/2147 of 3 December 2021 on the approval of civil aviation security equipment with ‘EU Stamp’ marking (Text with EEA relevance)Commission Implementing Decision (EU) 2021/2148 of 3 December 2021 on the unresolved objections regarding terms and conditions of the authorisation of the biocidal product family Oxybio in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2021) 8690) (Text with EEA relevance)Commission Implementing Decision (EU) 2021/2149 of 3 December 2021 on unresolved objections regarding the terms and conditions of the provisional authorisation of a biocidal product containing 5-Chloro-2-methyl-2H-isothiazol-3-one (C(M)IT) referred by France in accordance with Article 36(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2021)8693) (Text with EEA relevance)Commission Implementing Decision (EU) 2021/2164 of 3 December 2021 allowing Belgium to authorise biocidal products consisting of in-situ generated nitrogen for the protection of cultural heritage (notified under document C(2021) 8670) (Only the Dutch and French texts are authentic)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next